However, as time goes by and insulin treatment is prolonged over the years, the risk of hypoglycemia increases, and a basal insulin such as glargine may reduce the hypoglycemia risk as compared with NPH, even in this subgroup of obese people. This evidence concerns the gene INS and Hypoglycemia.